Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)

计划入组 342 人 · 首次发布于 2021 年 3 月 19 日

Neoadjuvant Cardonilizumab Combined With Neoadjuvant Chemoradiotherapy Can Resect Locally Advanced Esophageal Squamous Cell Carcinoma

计划入组 336 人 · 首次发布于 2026 年 7 月 13 日

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

计划入组 84 人 · 首次发布于 2007 年 11 月 16 日

neoadjuvant glioma vaccine

Nimotuzumab

Rx

Envafolimab

Rx

Neoadjuvant Immunochemoradiotherapy Shows Similar Efficacy to Chemoradiotherapy in ESCC

Immunotherapy Plus Chemoradiation Improves Outcomes in Esophageal Cancer

Tislelizumab Plus Chemoradiotherapy Shows Superior Response Rates in Gastric Cancer Trial